Anti-LCTL monoclonal antibody

Pre-made anti-LCTL monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LCTL/LCTL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1073-Ab-1/ GM-Tg-hg-IP1073-Ab-2Anti-Human LCTL monoclonal antibodyHuman
GM-Tg-rg-IP1073-Ab-1/ GM-Tg-rg-IP1073-Ab-2Anti-Rat LCTL monoclonal antibodyRat
GM-Tg-mg-IP1073-Ab-1/ GM-Tg-mg-IP1073-Ab-2Anti-Mouse LCTL monoclonal antibodyMouse
GM-Tg-cynog-IP1073-Ab-1/ GM-Tg-cynog-IP1073-Ab-2Anti-Cynomolgus/ Rhesus macaque LCTL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1073-Ab-1/ GM-Tg-felg-IP1073-Ab-2Anti-Feline LCTL monoclonal antibodyFeline
GM-Tg-cang-IP1073-Ab-1/ GM-Tg-cang-IP1073-Ab-2Anti-Canine LCTL monoclonal antibodyCanine
GM-Tg-bovg-IP1073-Ab-1/ GM-Tg-bovg-IP1073-Ab-2Anti-Bovine LCTL monoclonal antibodyBovine
GM-Tg-equg-IP1073-Ab-1/ GM-Tg-equg-IP1073-Ab-2Anti-Equine LCTL monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1073-Ab-1/ GM-Tg-hg-IP1073-Ab-2; GM-Tg-rg-IP1073-Ab-1/ GM-Tg-rg-IP1073-Ab-2;
GM-Tg-mg-IP1073-Ab-1/ GM-Tg-mg-IP1073-Ab-2; GM-Tg-cynog-IP1073-Ab-1/ GM-Tg-cynog-IP1073-Ab-2;
GM-Tg-felg-IP1073-Ab-1/ GM-Tg-felg-IP1073-Ab-2; GM-Tg-cang-IP1073-Ab-1/ GM-Tg-cang-IP1073-Ab-2;
GM-Tg-bovg-IP1073-Ab-1/ GM-Tg-bovg-IP1073-Ab-2; GM-Tg-equg-IP1073-Ab-1/ GM-Tg-equg-IP1073-Ab-2
Products NameAnti-LCTL monoclonal antibody
Formatmab
Target NameLCTL
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LCTL monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1073-Ag-1Recombinant multi-species LCTL/ KLG/ KLPH protein


    Target information

    Target IDGM-IP1073
    Target NameLCTL
    Gene ID197021,235435,315750,710515,487611,101101641,518599,100053000
    Gene Symbol and SynonymsE130104I05Rik,KLG,KLPH,LCTL
    Uniprot AccessionQ6UWM7
    Uniprot Entry NameLCTL_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000188501
    Target ClassificationN/A

    The target: LCTL, gene name: LCTL, also named as KLG, KLPH. This gene encodes a member of family 1 glycosidases. Glycosidases are enzymes that hydrolyze glycosidic bonds and are classified into families based on primary amino acid sequence. Most members of family 1 have two conserved glutamic acid residues, which are required for enzymatic activity. The mouse ortholog of this protein has been characterized and has a domain structure of an N-terminal signal peptide, glycosidase domain, transmembrane domain, and a short cytoplasmic tail. It lacks one of the conserved glutamic acid residues important for catalysis, and its function remains to be determined (PMID: 12084582). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.